This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Stefan McDonough, Ph.D.
Senior Vice President, Head of Neuroscience at Atalanta Therapeutics
Speaker

Profile

Stefan McDonough is Senior Vice President and Head of Neuroscience at Atalanta Therapeutics. He previously served as Executive Director, Genetics at Pfizer, and in scientific roles of increasing responsibility at Amgen, in the Neuroscience department and as head of Amgen's genome analysis unit. He holds a PhD in biology from Caltech and completed postdoctoral studies at Harvard Medical School and the University of Maryland Medical School. He is author on over 40 peer-reviewed publications and several book chapters and is Adjunct Professor of Brain Science at Brown University.

Agenda Sessions

  • Silencing Gain-of-function KCNT1 Genetic Epilepsy with Divalent siRNA, A Novel Small Interfering RNA Technology, Durably Eliminates Spontaneous Seizures in a Mouse Epilepsy Model

    8:30am